Two series of investigations utilizing laser-induced fluorescence (LIF) in characterizing diseased tissue are presented. In one in vitro investigation we studied the fluorescence from normal and atheroscierotically diseased arteries. In another, clinical, study we investigated the fluorescence in vivo from superficial urinary bladder malignancies in patients who had received a low-dose injection of Hematoporphyrin Derivative (HpD). Additionally, the fluorescence properties of L-tryptophan, collagen-I powder, elastin powder, nicotinamide adenine dinucleotide and i3-carothene were investigated and compared with the spectra from the tissue samples. A nitrogen laser (337 nm) alone or in connection with a dye laser (405 urn) was used together with an optical multichannel analyzer (OMA) to study the fluorescence spectra. The fluorescence decay characteristics of atherosclerotic plaque were examined utilizing a mode locked argon ion laser, synchronously pumping a picosecond dye laser. A fast detection system based on photon counting was employed. The fluorescence decay curves were evaluated on a PC computer allowing up to three lifetime components to be determined. A fluorescence peak at 390 nm in fibrotic plaque was identified as due to collagen fibers, while a fluorescence peak at 520 nm was connected to i3-carothene. The in vivo measurements of urinary bladder malignancies were performed with the optical fiber of the OMA system inserted through the biopsy channel of a cystoscope during the diagnostical procedure. The spectral recordings from urinary bladders, obtained at 337 nm and 405 nm excitation, revealed fluorescence features which can be used to demarcate tumor areas from normal mucosa. The fluorescence emission might also be useful to characterize different degrees of dysplasia.
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Apart from the diagnosis of malignant tus, LIF may be incorporated for guiding the procedure of laser angioplasty, a field in which a remarkable development has occurred during the last few years. Percutaneously performed laser angioplasty has opened up possibilities for easy and convenient treatment of narrowed or obstructed vessels also for patients in a poor general condition excluding them from major surgical procedures. Laser angioplasty utilizing the thermal effects of a Nd:YAG laser has successfully been used in large, peripheral arteries. Also, non-thermal excimer laser ablation has been used in peripheral arteries. Recently, the fits. 3reports on excimer laser ablation of coronary arteries have been published.
Reported complications utilizing laser angioplasty are dissection and perforation of the vessels. In cases of peripheral artery procedures this complication may not be severely damaging. However, in cases of coronary angioplasty such complications must be avoided. A guiding system for the laser action would improve the possibility to monitor the procedure inside the vessels and offer a better controlled laser ablation. The fluorescence characteristics from diseased and non-diseased areas of the vessel wall show remarkable spectral differences.
In this paper we report on two series of investigations in which we used LIF for tissue demarcation. In the first investigation we studied the in vitro fluorescence from human artery samples and showed that the autofluorescence is sufficient to demarcate normal vessel wall from atheroscierotically diseased tissue, and also that the in vitro fluorescence can be used to distingguish different tissue layers of atherosclerotic plaques and normal vessel wall. Furthermore, we have shown, that the in vitro fluorescence can be used to distingguish different stages of atherosclerosis. Thus, early fibrotic lesions can be distinguished from plaque regions with higher fat content and also from calcified plaque regions. The results are compared with the results from fluorescence recordings of a few pure substances and the origin of the different fluorescence bands are discussed. In the second trial we performed a clinical in vivo investigation on patients with different kinds of superficial bladder lesions including various degree of dysplasia and cancer in situ. The patients had been injected with a low dose of HpD.
MATERIAL AND METHODS
2.1. Fluorescence spectral recordings. As an excitation source a nitrogen laser (Laser Science VSL 337) was used alone or in conjunction with a dye laser, producing 3 ns pulses at 337 nm and 405 nm, respectively. The laser light was directed into a 600 im fluorescence free quartz fiber, which was placed in contact with the object. shown. In the lower middle the spectrum of removed material from the lipidic part of the same plaque (e) and to the lower right the spectrum from the surface of a non-diseased artery wall (f) are presented. The fibrotic plaque differs from the normal wall through a much stronger fluorescence intensity at 390 nm. This is in agreement with previous studies by us and others, where the same difference was found between the surface of a plaque region and normal Fig. 1 . Fluorescence spectra from the superficial fibrotic layer (a), hpid rich layer (b), the media (c) and the adventitia (d) of a plaque region. Also a spectrum from the hpid contents of the same fatty plaque is shown (e). Finally, a spectrum from the surface of a non-diseased artery wall in given (1) . The excitation wavelength was 337 nm.
vessel wall.27'33 The two spectra from lipid rich material (b and e), especially the one from removed lipid content (e), also exhibit special features. A fluorescence band is peaking at about 520 nm. This characteristic feature can be used to recognize lipidic regions ofjaque. The spectral dip at 420 nm is due to the reabsorption by hemoglobin '
The origin of the different fluorescence bands is of importance for determination of a suitable plaque demarcation criterion to be used in a guiding system for percutaneous laser ablation. Hence, the fluorescence from some selected pure substances was studied. The results are presented in Fig. 2 , where the fluorescence spectra from L-tryptophan, collagen-I powder, elastin powder, NADH and i3-carothene are presented. The spectra are not plotted on the same scale and should be compared only regarding the spectral shape. As already pointed out above, there is a major difference between plaque and normal vessel wall at about 390 nm. In Fig. 2 we can find three possible candidates contributing to this peak namely tryptophan, collagen or elastin. Collagen is a very brightly fluorescing substance with its fluorescence maximum at 390 nm.
Elastin has a very broad spectral width of the fluorescence with the peak at about 410 nm. It is likely that the fluorescence at 390 nm is a mixture of the spectral contributi from collage and elastin with higher collagen signal in the fibrotic plaque. Also tryptophan may contribute to the signal at 390 nm. Fluorescence spectra from L-t,yptophan, collagen I powder, powdee' NADH and i3-carothene. The excitation wavelength was 337 nm.
elastin
In the spectra shown in Fig. 1 to be present in lipid-rich plaques, is responsible for the fluorescence peak at 520 nm. In Fig. 2 the fluorescence spectrum of NADH is also presented. NADH has been ejorted to be the major fluorophore in, e.g., muscle tissue under UV excitation.
Such a fluorescence band cannot be observed in the plaque spectra in Fig. 2 .
In order to get more information from the fluorescence the decay time of the fluorescence was studied for the plaque samples as well as for the pure substances. Including this information in the fluorescence analysis, more reliable conclusions can be drawn. The results from the fluorescence decay time measurements are listed in Table I Table I . Fluorescence decay data for L-ttyptophan, collagen I powder, elastin powder, !3-carothene and NADH. The excitation wavelength was 337 nrn. The data listed are wavelength (ns), fluorescence decay amplitudes (%) and fluorescence decay times (ns) according to 1(t) = Ak exp(-t/-rk) the normal artery and, on the other hand, media and adventitia. The fluorescence decay times for fibrotic plaque at 380 nm are longer than those for non-diseased tissue. Furthermore, the amplitude of the slow decay component is stronger than for e.g. normal vessel wall, resulting in a slower overall fluorescence decay for the fibrotic plaque layer. The amplitude of the slow decay component is also very high for pure collagen, higher than that for elastin. The fluorescence characteristics with a prominent fluorescence band at 390 nm and a slow fluorescence decay, are in agreement with the biological composition of fibrotic plaque tissue with a high content of collagen fibers.
As already mentioned above, the fluorescence spectrum of tryptophan is quite similar to that of collagen for 337 nm excitation. However, it is clear from Table I that the fluorescence decay time is much shorter for tryptophan than for collagen and elastin. Thus, tryptophan may not contribute to the fluorescence for the excitation wavelength used. excitation wavelength was 405 nm. Two typical fluorescence spectra from tumor and normal mucosa are also shown. The autofluorescence signal at about 470 nm is denoted B, while the drug specific fluorescence at 630 nm is marked with an A. As seen in the figure there is a clear sign of the drug related fluorescence peaking at about 630 nm and 690 nm in the tumor spectrum, while no such porphyrin signature can be recognized in the spectrum from the normal mucosa. Another clear difference between the two spectra is the intensity of the autofluorescence (B), with a low intensity in the tumor area and a much higher in the normal mucosa. If the drug specific fluorescence at 630 nm is divided by the autofluorescence signal at 470 nm an enhanced demarcation of the tumor area is obtained. This is illustrated in Fig. 3 where the intensities of A and B are plotted together with the dimensionless ratio A/B.
In Fig. 4 fluorescence emission spectra from normal bladder mucosa and a superficial malignant tumor are shown for excitation at wavelengths 405 nm and 337 nm in a patient injected with 0.35 mg/kg b.w. Photofrin 48 hours prior to the investigation. As can be seen in the figure the tumor area is recognized by a very low autofluorescence intensity in the blue-green wavelength region for both excitation wavelengths. The drug specific signal at about 630 nm can be identified for both excitation wavelengths although better at 405 nm, which is close to the prominent absorption peak for porphyrin at 405 nm. The spectra excited at 337 nm show another difference in the autofluorescence with the The tumor spectrum obtained at 337 nm excitation is also shown for 10 times intensity magnification. The patient had been injected with 0.35 mg/kg b.w. In Fig. 5 we give some examples of the fluorescence signature of two different stages of dysplastic transformation, mild and severe dysplasia in the bladder wall together with the signature of normal mucosa. The autofluorescence peaking at about 470 nm shows a decreasing intensity in the regions of dysplasia. Beside the difference in the autofluorescence there is also a sign of porphyrin in the spectra from the dysplastic regions, which is not seen in the spectrum from the normal mucosa. A known chromophore fluorescing at about 470 nm is NADH. It has been suggested by us and others that the decreas139autofluorescence in malignant tissue might be due to less content of NADH . It is very likely that the decrease of the autofluorescence is due to a decreasing content of NADH as the dysplastic transformation of the bladder wall proceeds. 
